Bath & Body Works price target lowered to $17 from $38 at Telsey Advisory

Telsey Advisory lowered the firm’s price target on Bath & Body Works to $17 from $38 and keeps a Market Perform rating on the shares. Bath & Body’s Q3 results missed expectations due to softer sales and weaker margins, with Q4 guidance signaling continued challenges amid macro pressure, the analyst tells investors in a research note. While the company remains a well-known brand with a loyal customer base, recovery is taking longer than anticipated, and topline and margin improvement is unlikely until the second half of 2026, limiting near-term visibility, Telsey says.